Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Shilpa Medicare Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

54/100
409.50
-1.75 (-0.43%)

As on 21 Apr, 2026 | 10:54

Open Trading A/c
Day Range
408.50
414.00
L H
52 Week Range
259.50
500.00
L H
Volume
62,567
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
6 409.15 410.10 47
32 409.10 410.15 234
23 409.00 410.20 20
22 408.95 410.25 11
276 408.90 410.30 1
23435 Total Total 17452
Bid / Ask
409.15 / 410.10
54/100
410.00
-0.70 (-0.17%)

As on 21 Apr, 2026 | 10:54

Open Trading A/c
Day Range
408.05
414.00
L H
52 Week Range
260.00
501.60
L H
Volume
9,657
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
6 409.15 410.10 47
32 409.10 410.15 234
23 409.00 410.20 20
22 408.95 410.25 11
276 408.90 410.30 1
23435 Total Total 17452
Bid / Ask
409.15 / 410.10
NSE
MC Essentials
76% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 412.60
          Previous Close 411.25
          Volume 62,567.00
          Value (Lacs) 256.21
            VWAP 411.25
          Beta
          Mkt Cap (Rs. Cr.) 8,009
          High 414.00
          Low 408.50
          UC Limit 493.50
          LC Limit 329.00
          52 Week High 500.00
          52 Week Low 259.50
          Face Value 1.00
          All Time High 500.00
          All Time Low 22.63
          20D Avg Volume 1,064,832
          20D Avg Delivery(%) 27.13
          Book Value Per Share 127.41
          Dividend Yield 0.00
          TTM EPS See historical trend 7.67 (+91.61% YoY)
          TTM PE See historical trend 53.39 (Average PE)
          P/B See historical trend 3.22 (Low P/B)
          Sector PE 39.83

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          54/100
          Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 18.07% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 40.13% in Mar 2026 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          14 out of 17 years Shilpa Medicare has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 48.78% (2020) 16.18% -10.93% (2015) -6.19% 12.23%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Shilpa

          What's your call on Shilpa today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          23 Jan, 2025

          Ubs Ag

          Qty 163006 Price 818.05 % Traded 0.17
          23 Jan, 2025

          Ubs Principal Capital Asia Limited

          Qty 163006 Price 818.05 % Traded 0.17

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          21 Mar, 2025

          The Vanguard Group Inc Ac Vanguard Total International Stock Index Fund

          Qty 547853 Price 683.03 % Traded 0.56

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          21 Mar, 2025

          the vanguard group inc ac vanguard total international stock index fund

          Qty 547,853 Price 683.03 % Traded 0.00
          23 Jan, 2025

          ubs ag

          Qty 163,006 Price 818.05 % Traded 0.00
          23 Jan, 2025

          ubs principal capital asia limited

          Qty 163,006 Price 818.05 % Traded 0.00
          13 Dec, 2024

          priya inani

          Qty 100,000 Price 837.45 % Traded 0.10
          26 Sep, 2024

          vishnukant chaturbhuj bhutada

          Qty 1,000,000 Price 858.00 % Traded 1.04
          26 Sep, 2024

          ramakant innani

          Qty 675,000 Price 858.00 % Traded 0.70
          26 Sep, 2024

          dharmavati bhutada

          Qty 675,000 Price 858.00 % Traded 0.70
          26 Sep, 2024

          deepak kumar innani

          Qty 675,000 Price 858.00 % Traded 0.70

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Shilpa Medicare Ltd produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.The product range of the company includes Oncology AP`s-Anastrozole,Bicalutamide,Carboplatin ,Gemcitabine HCI, Irinotecan HCl Trihydrate,etc.General APIs-Ambroxol HCl,Ticlopidine HCl,Buflomedil HCl ,Nifedipine ,Lamivudine ,etc.PRODUCTS UNDER DEVELOPMENT (Oncology)- Bendamustine Cladribine, Decitabine Disodium Pamidronate, Epirubicin Exemustane, Fludarabine Phosphate Idarubicine,etc.NUTRITIONAL SUPPLEMENTS-Chromium picolinate Chromium polynicotinate.DRUG INTERMEDIATES-Trans-4-amino cyclohexanol,2-Amino-3,5-dibromobenzaldehyde,1,3,5-Trimethoxy Benzene ,etc..The company also engagged in the business of Power, Bulk Drugs and Intermediates.
          {"success":1,"data":{"address":{"address1":"12-6-214\/A-1,","address2":"Shilpa House,,Hyderabad Road,","city":"Raichur","state":"Karnataka","pincode":"584135","telephone1":"08532-238704","telephone2":"","fax1":"08532-238876","fax2":"","email":"info@vbshilpa.com","web":"http:\/\/www.vbshilpa.com"},"management":[{"name":"Omprakash Inani","designation":"Chairman"},{"name":"Vishnukant C Bhutada","designation":"Managing Director"},{"name":"Kalakota Sharath Reddy","designation":"Whole Time Director"},{"name":"Hetal Madhukant Gandhi","designation":"Independent Director"},{"name":"Anita Bandyopadhyay","designation":"Independent Woman Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"530549","nseId":"SHILPAMED","series":"EQ","isinid":"INE790G01031"}}}
          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Omprakash Inani

              Chairman

            • Vishnukant C Bhutada

              Managing Director

            • Kalakota Sharath Reddy

              Whole Time Director

            • Hetal Madhukant Gandhi

              Independent Director

            • Anita Bandyopadhyay

              Independent Woman Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              530549

            • NSE:

              SHILPAMED

            • Series

              EQ

            • ISIN

              INE790G01031

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347